Senior Director Clinical Biomarkers, BioPharma Business Development

The Senior Director Clinical Biomarkers, BioPharma Business Development will provide strategic, scientific, and organizational leadership across a broad oncology diagnostics portfolio. This executive will be responsible for defining and advancing biomarker and translational medicine strategies across early- and late-stage BioPharma collaborations in support of Natera’s strategic goals eg TOMR and surrogacy in collaboration with Natera’s lifecycle and clinical development teams. The ideal candidate will bring deep expertise in oncology drug development, biomarker strategy, and translational research, with experience spanning Phase 1–3 studies and multiple therapeutic modalities, including immunotherapy, targeted therapy, and antibody-drug conjugates. &